Clinical Trials on Human Immunodeficiency Virus Infection in France

Total 2102 results

Hospices Civils de Lyon

Completed

COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)

Infection Viral

France
Crucell Holland BV
National Institutes of Health (NIH); Division of Microbiology and Infectious...

Withdrawn

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Influenza

United States, Australia, Canada, France, Germany, Spain, Belgium, Bulgaria, Netherlands, Brazil, South Africa, Sweden
Institut National de la Santé Et de la Recherche...

Suspended

Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.

Coronavirus

France, French Guiana
Centre Hospitalier Universitaire de Nice

Completed

Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients (PredictCovidT)

Coronavirus Infection | Kidney Transplant; Complications

France
Hoffmann-La Roche

Completed

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Influenza

Italy, United States, Spain, Hungary, France, Lithuania, Romania, Poland, Denmark
Imagine Institute

Recruiting

Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked (CARDOVID)

COVID-19 Infection

France
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

Influenza

United States, Germany, Poland, Spain, Czechia, Bangladesh, France
Central Hospital, Nancy, France

Not yet recruiting

Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study) (TACIT2)

COVID-19 | Antiphospholipid Syndrome

France
Assistance Publique - Hôpitaux de Paris

Completed

COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants (COVIDOCRECHE)

Coronavirus Infection | Covid19 | Coronavirus | Sars-CoV2

France
Ansun Biopharma, Inc.
National Institutes of Health (NIH)

Completed

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

Influenza

United States
The Immunobiological Technology Institute (Bio-Manguinhos)...
Hospital de Clinicas de Porto Alegre

Unknown

BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C (BIP48II/III)

Chronic Hepatitis C

Brazil
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients (CONCERVIC)

Hepatitis C | Renal Allograft

Brazil
University Hospital, Limoges

Completed

A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. (ORPHAVIC)

Transplant Recipients With CMV Infection

France
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Ensemble contre le SIDA

Completed

Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients (HEPAVAC)

HIV Infection

France
Bristol-Myers Squibb

Completed

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment (HEPCAT)

Hepatitis C Virus

Australia, France, Mexico, United States, Canada, Germany, Denmark, Italy, Puerto Rico, Sweden, Argentina
Assistance Publique - Hôpitaux de Paris

Unknown

Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers (BURDENCOV)

Corona Virus Infection | Post-traumatic Stress Disorder

France
Bristol-Myers Squibb

Completed

Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment

Chronic Hepatitis B

Germany, Italy, France, Spain, Netherlands, Poland, Romania
Centre Hospitalier Universitaire de Nice

Recruiting

Epstein-Barr Virus Implication in Peri-implantitis: Towards an Innovative Etiopathogenic Model. (PERIVIR)

Peri-Implantitis

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts (VAC-WARTS)

Palmar or Plantar Warts

France
Assistance Publique - Hôpitaux de Paris

Suspended

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO (CORIMUNO-VIRO)

SARS-CoV-2 Infection | COVID19

France
Institut National de la Santé Et de la Recherche...

Suspended

Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. (Cov-CONTACT)

Coronavirus

France, French Guiana
Centre Hospitalier Universitaire de Nīmes

Completed

FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDS (COVIDARRAY)

COVID-19 | SARS-CoV2 Infection | Ventilator Associated Pneumonia | Ards

France
Central Hospital, Nancy, France

Not yet recruiting

Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic (VirCoV+)

Viral Pneumonia

France
Assistance Publique Hopitaux De Marseille

Unknown

Role of the Balano-preputial Furrow 's Microbiota, in Circumcised Patients or Not, in the Acquisition or Transmission of HIV

HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (TRANSBioHIV)

HIV Infection

France
Centre Hospitalier Universitaire de Nice

Unknown

Impact of Raltegravir on the Viral Reservoirs

HIV Infection

France
Centre Hospitalier Universitaire de Nīmes

Completed

Ventilation Associated Pneumonia and Covid-19 (ECOLCOVID)

COVID-19 | SARS-CoV2 Infection | Ventilator Associated Pneumonia | Ards

France
French Cardiology Society
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study (MODIF)

Myocardial Infarction

France
Groupe Hospitalier Pitie-Salpetriere
CMC Ambroise Paré

Completed

Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (CovidTox)

Iatrogenic Disease | Acute Kidney Injury | Coronavirus | ARDS, Human

France
ANRS, Emerging Infectious Diseases

Unknown

Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV) (Lympho C)

Chronic Hepatitis C

France
Bristol-Myers Squibb

Completed

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) (Hallmark QUAD)

Hepatitis C Virus

United States, Germany, Italy, Korea, Republic of, Sweden, Russian Federation, Canada, France, Argentina, Switzerland, Denmark, Taiwan, Netherlands, Spain, Mexico
Janssen Sciences Ireland UC

Completed

A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)

Healthy | Hepatitis, Chronic

France, Taiwan, Spain, Belgium, Bulgaria, Malaysia, Romania, Germany, Georgia, Moldova, Republic of
Janssen-Cilag International NV

Completed

A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants (COMMIT)

Hepatitis C, Chronic

France, United Kingdom, Belgium, Spain, Germany, Hungary
Bristol-Myers Squibb

Completed

Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) (Hallmark DUAL)

Hepatitis C Virus

France, Germany, Korea, Republic of, Spain, Taiwan, United States, Canada, Australia, Russian Federation, Austria, Israel, Italy, Netherlands, Argentina, Poland, United Kingdom, Ireland, New Zealand
University Hospital, Montpellier
University Hospital, Marseille; Lyon Civil Hospitals - Lyon Sud Hospital Center

Completed

Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection

COVID 19

France
AbbVie

Completed

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

Hepatitis C Virus (HCV)

United States, Bulgaria, Canada, France, Germany, Poland, Puerto Rico, Russian Federation, Spain, United Kingdom
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants

Influenza

Belgium, Israel, Italy, Spain, United States, Germany, Canada, France, Estonia, Poland, Hungary, Lithuania, United Kingdom, Czech Republic
Assistance Publique - Hôpitaux de Paris
INSERM, Epopé team

Recruiting

Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns (Coropreg)

Pregnancy Complications | Neonatal Complications | covid19 Infection

France
Assistance Publique - Hôpitaux de Paris
INSERM CESP1018

Completed

Sexual Needs of Adolescents Living With HIV Since Childhood (SSVIH)

Hiv | Perinatal HIV Infection

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 (TOCIDEX)

Coronaviridae Infections | Nidovirales Infections | RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Coronavirus Infection | SARS (Severe Acute Respiratory Syndrome) | Respiratory Tract Disease

French Guiana
University Hospital, Limoges

Terminated

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test. (QUANTIC-R+)

Renal Transplant Recipient | Immunized Against the Cytomegalovirus

France
Janssen Research & Development, LLC

Active, not recruiting

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants (OCTOPUS-1)

Hepatitis B, Chronic

France, Canada, Czechia, Italy, Taiwan, Turkey, Spain, United Kingdom
Assistance Publique - Hôpitaux de Paris

Recruiting

Foreign Body Ingestion During COVID-19 Lockdown (COCE)

Foreign Body Ingestion

France
Central Hospital, Nancy, France

Completed

SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

COVID-19 Infection

France
Osivax
CIC 1417 Cochin Pasteur Hôpital Cochin Paris France

Active, not recruiting

First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers

Coronavirus

France
Janssen Infectious Diseases BVBA
Vertex Pharmaceuticals Incorporated

Completed

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Genotype 1 Chronic Hepatitis C | Treatment Naive

United States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
Protein Sciences Corporation

Completed

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Influenza

United States
Bristol-Myers Squibb

Completed

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin (D-LITE)

Hepatitis C

France, Germany, Italy, Japan, United States, Australia, Puerto Rico, Spain, New Zealand
Gilead Sciences

Completed

Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection

Hepatitis C

Spain, Netherlands, Austria, France, United Kingdom, Italy, Estonia, Germany, Poland, Sweden
University Hospital, Montpellier

Completed

Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients (SENO-COVID)

Rheumatoid Arthritis | SARS-Cov-2 Infection

France

Clinical Trials on Human Immunodeficiency Virus Infection in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations